Ovation wins FDA advisers' support for seizure medicine

01/7/2009 | Chicago Tribune (tiered subscription model)

An FDA advisory panel unanimously endorsed approval of Sabril, a seizure medication from Ovation Pharmaceuticals, as adjunct therapy for patients who do not respond to other anti-epileptic treatments. Ovation plans to market Sabril for adults with refractory complex partial seizures.

View Full Article in:

Chicago Tribune (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN